Corcept Therapeutics | CORT - Dochód Netto





Dochód Netto Zmiana Data
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Ardelyx USD -407K 562K 2025-12
Assertio Holdings USD -2.92M 753K 2024-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
J&J USD 5.24B 119M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
TG Therapeutics USD 23.04M 367.86M 2025-12